Suppr超能文献

危重症患者的增强肾清除率:如何评估肾功能。

Augmented renal clearance in the critically ill: how to assess kidney function.

机构信息

Pharmacy Department, Research Unit for Clinical Pharmacy, University Hospitals Leuven, Belgium.

出版信息

Ann Pharmacother. 2012 Jul-Aug;46(7-8):952-9. doi: 10.1345/aph.1Q708. Epub 2012 Jun 12.

Abstract

BACKGROUND

Augmented renal clearance in critically ill patients can result in underdosing of life-saving drugs, potentially leading to therapeutic failure. To detect this phenomenon, correct assessment of the kidney function is essential. Currently, little is known about the validity of mathematical formulas to estimate renal function in this subset of patients.

OBJECTIVE

To evaluate the validity of different methods to estimate kidney function in critically ill patients with augmented renal clearance by comparing measured renal clearance with estimated clearance using different formulas.

METHODS

An observational, retrospective, single-center study was conducted in a 34-bed surgical intensive care unit (SICU) of the University Hospitals Leuven, Leuven, Belgium. Adults admitted to the SICU in 2010 with a measured creatinine clearance (CrCl) of 120 mL/min or more (based on 24-hour urinary collection) were included. The measured clearance values were compared with estimated clearance values as calculated by the Cockcroft-Gault (CrCl(CG)) method and the reexpressed 4-variable Modification of Diet in Renal Disease estimated glomerular filtration rate (eGFR) formula. Spearman rank order correlation was performed to determine the relationship between measured and estimated clearances. Bland-Altman plots were evaluated to assess bias and limits of agreement between the 2 methods.

RESULTS

Records on 1317 patients were screened. Augmented renal clearance was present in 390 patients. Spearman correlation showed fair correlation between measured and estimated clearances (r(s) = 0.343; p < 0.001 [CrCl(CG)] and r(s) = 0.290; p < 0.001 [eGFR]). Bias was -11.2 mL/min with limits of agreement (-131.7; 109.3 mL/min [CrCl(CG)]) and -19.9 mL/min with limits of agreement (-170.4; 130.7 mL/min [eGFR]).

CONCLUSIONS

Estimated renal clearances, such as the eGFR estimated by the MDRD formula or CrCl estimated by CG, showed poor agreement with measured CrCl values in our critically ill population displaying augmented renal clearance. Clinicians should be cautious when interpreting kidney function based on estimating equations in this subset of patients. Instead, measured CrCl using urinary collection is recommended in patients suspected of displaying augmented renal clearance.

摘要

背景

危重症患者的增强肾清除率可导致救命药物剂量不足,从而可能导致治疗失败。为了发现这种现象,对肾功能进行正确评估至关重要。目前,对于在这种亚组患者中估计肾功能的数学公式的有效性知之甚少。

目的

通过比较不同公式的测量肾清除率和估计清除率,评估不同方法估计增强肾清除率危重症患者肾功能的有效性。

方法

这是一项在比利时鲁汶大学附属医院的 34 张床位外科重症监护病房(SICU)进行的观察性、回顾性、单中心研究。纳入 2010 年入住 SICU 且测量肌酐清除率(CrCl)≥120 mL/min(基于 24 小时尿液收集)的成年人。将测量的清除值与 Cockcroft-Gault(CrCl(CG))法和重新表达的 4 变量肾脏病饮食改良估计肾小球滤过率(eGFR)公式计算的估计清除值进行比较。采用斯皮尔曼等级相关来确定测量值与估计值之间的关系。通过 Bland-Altman 图评估两种方法之间的偏差和一致性界限。

结果

对 1317 例患者的记录进行了筛选。390 例患者存在增强肾清除率。斯皮尔曼相关显示测量值与估计值之间存在适度相关性(r(s) = 0.343;p < 0.001 [CrCl(CG)]和 r(s) = 0.290;p < 0.001 [eGFR])。偏差为-11.2 mL/min,一致性界限为(-131.7;109.3 mL/min [CrCl(CG)])和-19.9 mL/min,一致性界限为(-170.4;130.7 mL/min [eGFR])。

结论

在存在增强肾清除率的危重症人群中,eGFR 通过 MDRD 公式估计或 CG 估计的 CrCl 等估计肾清除率与测量的 CrCl 值一致性较差。在该亚组患者中,基于估算方程解读肾功能时,临床医生应谨慎。相反,建议在怀疑存在增强肾清除率的患者中使用尿液收集来测量 CrCl。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验